Peri-operative morbidity and changes in symptom scores after transurethral prostatectomy in Switzerland: Results of an independent assessment of outcome

BJU International

Volumn 98, Issue 2, 2006, Pages 381-383

  Müntener, Michael ^a   Aellig, Sonja ^b   Küttel, Rolf ^b   Gehrlach, Christoph ^b   Hauri, Dieter ^a   Strebel, Räto T ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Verein Outcome   (Switzerland)

Author keywords

BPH; Complications; Outcome assessment; TURP

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROSTATECTOMY; QUESTIONNAIRE; SCORING SYSTEM; SURGICAL APPROACH; SWITZERLAND; SYMPTOMATOLOGY; TREATMENT OUTCOME; URINE RETENTION;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; INTRAOPERATIVE COMPLICATIONS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 33745684249     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06256.x     Document Type: Article

References (19)

1. Logie J, Clifford GM, Farmer RD. Incidence, prevalence and management of lower urinary tract symptoms in men in the UK. BJU Int 2005; 95: 557-62
2. Verhamme KM, Dieleman JP, Bleumink GS, Bosch JL, Stricker BH, Sturkenboom MC. Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project. Eur Urol 2003; 44: 539-45
3. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003; 170: 530-47
4. Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int 1999; 83: 227-37
5. Berges RR, Pientka L. Management of the BPH syndrome in Germany: who is treated and how? Eur Urol 1999; 36 (Suppl. 3): 21-7
6. Bruskewitz R. Management of symptomatic BPH in the US: who is treated and how? Eur Urol 1999; 36 (Suppl. 3): 7-13
7. Horninger W, Unterlechner H, Strasser H, Bartsch G. Transurethral prostatectomy: mortality and morbidity. Prostate 1996; 28: 195-200
8. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989; 141: 243-7
9. Uchida T, Ohori M, Soh S et al. Factors influencing morbidity in patients undergoing transurethral resection of the prostate. Urology 1999; 53: 98-105
10. Hald T, Nordling J, Andersen JT, Bilde T, Meyhoff HH, Walter S. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 1991; 138: 59-62
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83
12. Hoffman RM, MacDonald R, Slaton JW, Wilt TJ. Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review. J Urol 2003; 169: 210-5
13. Holtgrewe HL, Valk WL. Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2015 cases. J Urol 1962; 87: 450-9
14. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995; 332: 75-9
15. Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP. Immediate and postoperative complications of transurethral prostatectomy in the 1990s. J Urol 1999; 162: 1307-10
16. McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: problems and possible solutions. BMJ 2002; 324: 1448-51
17. Mansson A, Henningsohn L, Steineck G, Mansson W. Neutral third party versus treating institution for evaluating quality of life after radical cystectomy. Eur Urol 2004; 46: 195-9
18. Varkarakis J, Bartsch G, Horninger W. Long-term morbidity and mortality of transurethral prostatectomy: a 10-year follow-up. Prostate 2004; 58: 248-51
19. Madersbacher S, Lackner J, Brossner C et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23 123 cases. Eur Urol 2005; 47: 499-504